Dihydromonacolin L
CAS: 86827-77-2
Ref. 3D-LDA82777
5mg | Nachfragen | ||
10mg | Nachfragen | ||
25mg | Nachfragen | ||
50mg | Nachfragen |
Produktinformation
- 2H-Pyran-2-one, tetrahydro-4-hydroxy-6-[2-[(1S,2S,4aR,6R,8aS)-1,2,4a,5,6,7,8,8a-octahydro-2,6-dimethyl-1-naphthalenyl]ethyl]-, (4R,6R)-
- 4a,5-Dihydromonacolin L
- (4R,6R)-Tetrahydro-4-hydroxy-6-[2-[(1S,2S,4aR,6R,8aS)-1,2,4a,5,6,7,8,8a-octahydro-2,6-dimethyl-1-naphthalenyl]ethyl]-2H-pyran-2-one
Dihydromonacolin L is a kinase inhibitor that has shown promise in the treatment of cancer. It is derived from Chinese medicinal herbs and has been found to induce apoptosis, or programmed cell death, in cancer cells. Dihydromonacolin L has been shown to be effective against a variety of tumors, including leukemia, by inhibiting the cell cycle and inducing apoptosis. This compound is an attractive target for anticancer drug development due to its potent inhibitory activity against protein kinases. In recent studies, it has been found that Dihydromonacolin L can enhance the anticancer effects of nintedanib, another cancer drug. Overall, Dihydromonacolin L shows great potential as a new class of anticancer agents with promising therapeutic applications.
Chemische Eigenschaften
Technische Anfrage zu: 3D-LDA82777 Dihydromonacolin L
Wenn Sie ein Angebot anfordern oder eine Bestellung aufgeben möchten, legen Sie stattdessen die gewünschten Produkte in Ihren Warenkorb und fordern Sie dann ein Angebot oder eine Bestellung an aus dem Warenkorb. Es ist schneller, billiger und Sie können von den verfügbaren Rabatten und anderen Vorteilen profitieren.